المؤلفون: Huber, Rudolf M, Hansen, Karin H, Paz-Ares Rodríguez, Luis, West, Howard L, Reckamp, Karen L, Leighl, Natasha B, Tiseo, Marcello, Smit, Egbert F, Kim, Dong-Wan, Gettinger, Scott N, Hochmair, Maximilian J, Kim, Sang-We, Langer, Corey J, Ahn, Myung-Ju, Kim, Edward S, Kerstein, David, Groen, Harry J M, Camidge, D Ross

المصدر: Huber , R M , Hansen , K H , Paz-Ares Rodríguez , L , West , H L , Reckamp , K L , Leighl , N B , Tiseo , M , Smit , E F , Kim , D-W , Gettinger , S N , Hochmair , M J , Kim , S-W , Langer , C J , Ahn , M-J , Kim , E S , Kerstein , D , Groen , H J M & Camidge , D R 2020 , ' Brigatinib in Crizotinib-Refractory ALK+ NSCLC : 2-Year Follow-up on Systemic and ....

مصطلحات موضوعية: Anaplastic lymphoma kinase, ALK tyrosine kinase receptor, Brigatinib, Non-small cell lung cancer, CELL LUNG-CANCER, BRAIN METASTASES, OPEN-LABEL, RESPONSE ASSESSMENT, KINASE INHIBITOR, SOLID TUMORS, CERITINIB, CHEMOTHERAPY, RECIST, MULTICENTER

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/2c7f6739-7613-4877-9c71-f0a9427752f3Test

الإتاحة: https://doi.org/10.1016/j.jtho.2019.11.004Test
https://hdl.handle.net/11370/2c7f6739-7613-4877-9c71-f0a9427752f3Test
https://research.rug.nl/en/publications/2c7f6739-7613-4877-9c71-f0a9427752f3Test
https://pure.rug.nl/ws/files/119396618/Brigatinib_in_Crizotinib_Refractory_ALK_NSCLC_2_Year_Follow_up_on_Systemic_and_Intracranial_Outcomes_in_the_Phase_2_ALTA_Trial.pdfTest

المؤلفون: Clark, Jeffrey W, Camidge, D Ross, Kwak, Eunice L, Maki, Robert G, Shapiro, Geoffrey I, Chen, Isan, Tan, Weiwei, Randolph, Sophia, Christensen, James G, Ozeck, Mark, Tang, Yiyun, Wilner, Keith D, Salgia, Ravi

المصدر: Future Oncology; Jan2020, Vol. 16 Issue 1, p4289-4301, 13p

مصطلحات موضوعية: THERAPEUTIC use of antineoplastic agents, PROTEINS, RESEARCH, DRUG dosage, CLINICAL trials, RESEARCH methodology, PROGNOSIS, ANTINEOPLASTIC agents, EVALUATION research, MEDICAL cooperation, COMPARATIVE studies, PROTEIN-tyrosine kinases, DOSE-effect relationship in pharmacology, GENES, TUMORS, LONGITUDINAL method, DRUG toxicity, CHEMICAL inhibitors

المؤلفون: Reckamp, Karen L., Giaccone, Giuseppe, Camidge, D. Ross, Gadgeel, Shirish M., Khuri, Fadlo R., Engelman, Jeff A., Koczywas, Marianna, Rajan, Arun, Campbell, Alicyn K., Gernhardt, Diana, Ruiz‐Garcia, Ana, Letrent, Stephen, Liang, Jane, Taylor, Ian, O'Connell, Joseph P., Jänne, Pasi A.

المصدر: Cancer (0008543X); Apr2014, Vol. 120 Issue 8, p1145-1154, 10p

مصطلحات موضوعية: PROTEIN-tyrosine kinase inhibitors, EPIDERMAL growth factor receptors, LUNG cancer patients, ERLOTINIB, CANCER chemotherapy, ADENOCARCINOMA

المؤلفون: Brosnan, Evelyn M., Weickhardt, Andrew J., Lu, Xian, Maxon, Delee A., Barón, Anna E., Chonchol, Michel, Camidge, D. Ross

المصدر: Cancer (0008543X); Mar2014, Vol. 120 Issue 5, p664-674, 12p

مصطلحات موضوعية: GLOMERULAR filtration rate, CHRONIC kidney failure, EPIDEMIOLOGY, LYMPHOMAS, SMALL cell lung cancer, CONFIDENCE intervals

المؤلفون: Weickhardt, Andrew J., Aisner, Dara L., Franklin, Wilbur A., Varella‐Garcia, Marileila, Doebele, Robert C., Camidge, D. Ross

المصدر: Cancer (0008543X); Apr2013, Vol. 119 Issue 8, p1467-1477, 11p

مصطلحات موضوعية: LUNG cancer, ADENOCARCINOMA, ANAPLASTIC lymphoma kinase, PROTEIN-tyrosine kinases, IN situ hybridization, FLUORESCENCE

المؤلفون: Bar, Jair^1,2 (AUTHOR) bar.jair@gmail.com, Esteban, Emilio³ (AUTHOR), Rodríguez-Abreu, Delvys⁴ (AUTHOR), Aix, Santiago Ponce⁵ (AUTHOR), Szalai, Zsuzsanna⁶ (AUTHOR), Felip, Enriqueta⁷ (AUTHOR), Gottfried, Maya⁸ (AUTHOR), Provencio, Mariano⁹ (AUTHOR), Robinson, Andrew¹⁰ (AUTHOR), Fülöp, Andrea¹¹ (AUTHOR), Rao, Suman Bannur¹² (AUTHOR), Camidge, D. Ross¹³ (AUTHOR), Speranza, Giovanna¹⁴ (AUTHOR), Townson, Steven M.¹⁵ (AUTHOR), Kobie, Julie¹⁵ (AUTHOR), Ayers, Mark¹⁵ (AUTHOR), Dettman, E.J.¹⁵ (AUTHOR), Hunkapiller, Nathan^1,16 (AUTHOR), McDaniel, Robert¹⁶ (AUTHOR), Jung, Byoungsok¹⁶ (AUTHOR)

المصدر: Lung Cancer (01695002). Apr2024, Vol. 190, pN.PAG-N.PAG. 1p.

مصطلحات موضوعية: *NON-small-cell lung carcinoma, *HEMATOMA, *CIRCULATING tumor DNA, *RECEIVER operating characteristic curves, *PEMBROLIZUMAB

المؤلفون: Patil, Tejas¹ tejas.patil@ucdenver.edu, Aisner, Dara L.², Noonan, Sinead A.³, Bunn, Paul A.³, Purcell, William T.³, Carr, Laurie L.⁴, Camidge, D. Ross³, Doebele, Robert C.³

المصدر: Lung Cancer (01695002). Jun2016, Vol. 96, p27-32. 6p.

مصطلحات موضوعية: *PERITONEAL cancer, *CANCER treatment, *NON-small-cell lung carcinoma, *ONCOGENES, *CANCER invasiveness, *EPIDERMAL growth factor receptors, *PATIENTS